Hemogenyx Pharmaceuticals Plc (HEMO)
Market Closed
16 Oct, 03:30 PM
LSE 
658. 00
GBX +44
+7.1661%
17.02M Market Cap
- P/E Ratio
- Div Yield
24,563 Volume
- Eps
614 GBX
Previous Close Want to track HEMO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Hemogenyx Pharmaceuticals Plc (HEMO) Statistics
Valuation metrics
Market Cap 17.02M
Enterprise value 42.65M
Trailing P/E (ttm) -3.64
Forward P/E -
PEG ratio -0.2
Price/Sales (ttm) -
Price/Book (mrq) 9.8
Enterprise Value/Revenue -
Enterprise Value/EBITDA -4.71
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 29.09K
Average volume (90 days) 22.06K
Price summary
52-Week low 356
52-Week high 1,220
Beta -
50-Day moving average 547.2
200-Day moving average 690.56
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:400
Last split Date 13 Dec 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.65%
Return on equity -4.1%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.76
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.71
Total debt (mrq) -
Total Debt/Equity (mrq) 0.43
Current ratio (mrq) 4.04%
Book value per share (mrq) 0.66
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
